Chronic relapsing experimental autoimmune encephalomyelitis (CR-EAE) was induced in Lewis rats by inoculation with guinea pig spinal cord and adjuvants and treatment with low dose cyclosporin A (CsA). Acute EAE was induced by the same method without CsA treatment. Immunocytochemistry and flow cytometry were used to assess inflammatory cells and MHC class II (Ia) antigen expression in the central nervous system of these rats. The inflammatory infiltrate was composed mainly of CD4 + T cells and macrophages, and a/3 T cells constituted about 65% of the CD2 ÷ T cells. After recovery from acute EAE and during the first remission of CR-EAE, the number of T cells was significantly less than in the preceding episodes. The number of T cells was higher in the second episode of CR-EAE than in the first remission. Throughout the course of CR-EAE, the majority of the CD2 ÷ T cells were CD45RC-. The ratio of IL-2R ÷ cells to CD2 ÷ cells ranged from 10.5 to 24.0%. The ratio of CD4 ÷ T cells to B cells was lower in the later episodes of CR-EAE than in the first episode. Ia antigen was expressed on infiltrating round cells at all stages of CR-EAE and on microglial cells (identified by dendritic morphology) with increasing intensity throughout the course of CR-EAE. With flow cytometry, the number of Ia + cells obtained from the spinal cord rose throughout the course of CR-EAE. The number of FSC~°wox1 l°w cells, which we consider represent microglia, also increased during the course of CR-EAE.
I. Introduction
In the Lewis rat, experimental autoimmune encephalomyelitis (EAE) is usually an acute monophasic illness; chronic relapsing EAE (CR-EAE) can be induced by inoculation with guinea pig spinal cord and adjuvants and treatment with low dose cyclosporin A (CsA) (Polman et al., 1988) . We have previously reported the neuropathological and electrophysiological findings in this model of CR-EAE (Pender et al., 1990; Stanley and Pender, 1991) . The means by which low dose CsA causes CR-EAE is not known. Polman et al. (1988) suggested that suppressor mechanisms are inactivated by CsA, or that relapses are a rebound effect * Corresponding author. Fax: (07) 3655 462.
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SSDI 0165-5728(94)00016-H after cessation of the drug. In our study of chronic relapsing experimental autoimmune neuritis induced by inoculation with intradural root myelin and adjuvants and treatment with low dose CsA, we also suggested that low dose CsA treatment interferes with the regulatory mechanisms which prevent relapses (McCombe et al., 1990) . One aim of the present study was to compare the immunopathology of acute EAE and CR-EAE, to search for effects of low dose CsA which might lead to relapses.
A second aim was to study the inflammatory infiltrate in the CNS during the course of CR-EAE, to determine whether it declined in clinical remission and intensified during relapse and whether the relative proportions of cells of different types varied throughout the course of CR-EAE. In the guinea pig (Traugott et al., 1982; Butter et al., 1989 ) and mouse (Traugott et
